Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1E | P49674 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 14/20 | 0.42 |
| ▸ | MMP1 | P03956 | 9/20 | 0.42 |
| ▸ | MMP3 | P08254 | 9/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | MMP7 | P09237 | 4/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8387575 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL8385145 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL2392222 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL8386222 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL25283495 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL1684230 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL25287896 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL8383203 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL337801 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL8381675 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12478065-B2 | Antimicrobial preservative compositions | SHARON LABORATORIES LTD. (IL) | 2025-11-25 | — | — | US | claimed |
| US-12257553-B2 | Separation membrane and methods of preparation thereof | ASPEN PRODUCTS GROUP, INC. (US) | 2025-03-25 | — | — | US | claimed |
| WO-2024165361-A1 | PREPARATION OF POLYISOCYANATES CONTAINING IMINOOXADIAZINEDIONE GROUPS AND THEIR USE | BASF SE (DE) | 2024-08-15 | — | — | WO | claimed |
| WO-2023138938-A1 | PREPARATION OF POLYISOCYANATES CONTAINING IMINOOXADIAZINEDIONE GROUPS AND THEIR USE | BASF SE (DE) | 2023-07-27 | — | — | WO | claimed |
| EP-4146765-B1 | A METHOD AND REAGENTS FOR ENHANCING THE CHEMILUMINESCENT SIGNAL | EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (DE) | 2023-07-05 | — | — | EP | claimed |
| CN-109789216-B | Topical skin treatment formulations based on ionic species | 加利福尼亚大学董事会 | 2023-05-23 | — | — | CN | claimed |
| US-20230002676-A1 | TREATMENT LIQUID AND TREATMENT LIQUID CONTAINER | FUJIFILM CORPORATION (JP) | 2023-01-05 | — | — | US | claimed |
| WO-2022026968-A1 | SEPARATION MEMBRANE AND METHODS OF PREPARATION THEREOF | ASPEN PRODUCTS GROUP, INC. (US) | 2022-02-03 | — | — | WO | claimed |
| US-20220032240-A1 | Separation Membrane and Methods of Preparation Thereof | ASPEN PRODUCTS GROUP, INC. (US) | 2022-02-03 | — | — | US | claimed |
| EP-2964725-B1 | COMPOSITIONS AND METHODS FOR SELECTIVELY ETCHING TITANIUM NITRIDE | ENTEGRIS INC (US) | 2021-06-23 | — | — | EP | claimed |
| EP-0878281-B1 | Microbicidal agents | LANXESS DEUTSCHLAND GMBH (DE) | 2006-03-22 | — | — | EP | claimed |
| EP-0740528-B1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX THERAPEUTICS INC (US) | 2003-03-26 | — | — | EP | claimed |
| EP-0707489-A4 | ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF | SCOTGEN BIOPHARMACEUTICALS INC (US) | 1998-07-29 | — | — | EP | claimed |
| EP-0599188-B1 | Trans and CIS traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity | LIFEGROUP SPA (IT) | 1997-08-06 | — | — | EP | claimed |
| US-5567716-A | FOR THE THERAPEUTIC TREATMENT OF CUTANEOUS PATHOLOGIES | LIFEGROUP S.P.A. (IT) | 1996-10-22 | — | — | US | claimed |
| EP-0707489-A1 | ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF | Scotgen Biopharmaceuticals, Inc. (US) | 1996-04-24 | — | — | EP | claimed |
| WO-1994025053-A1 | ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF | SCOTGEN BIOPHARMACEUTICALS, INC. (US) | 1994-11-10 | — | — | WO | claimed |
| EP-0599188-A1 | Trans and CIS traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity | LIFEGROUP S.p.A. (IT) | 1994-06-01 | — | — | EP | claimed |
| EP-0141628-B1 | ANTIMICROBIAL LATEX COMPOSITION SHAPED ARTICLE PRODUCED THEREFROM, AND METHOD OF MANUFACTURING A SHAPED ARTICLE | UNITIKA LTD. (JP) | 1989-10-18 | — | — | EP | claimed |
| US-4675347-A | Antimicrobial latex composition | UNITIKA LTD. (JP) | 1987-06-23 | — | — | US | claimed |